Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Conjugated Linoleic Acid and Leptin

Research Papers that Mention the Interaction

CLA supplementation might moderately decrease circulatory leptin levels only among obese adults for shorter than 24 weeks.
Random-effect meta-analysis found a slight but not significant reduction in plasma leptin concentrations (WMD: -0.38 ng/ml, 95% CI: -1.08, 0.32, p=0.286); I2=53.24%, p=0.001), following CLA supplementation.
Subgroup analysis based … showed that the CLA … leptin when used for obese subjects (WMD: -1.47 ng/ml, 95% CI: -2.15, -0.79, p<0.001) and in … trials lasting<24 weeks of duration (WMD: -0.76 ng/ml, 95% CI: -1.40, -0.12, p=0.019).
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  •  2018  |  View Paper
CONCLUSION CL su pplementation might be able to decrease circulating lep tin le vels in studies with duration of less than 8 weeks especially among male and overweight subjects.
Endocrine, metabolic & immune disorders drug targets  •  2018  |  View Paper
Analysis of plasma leptin concentrations adjusted for adiposity by using fat mass as a covariate showed that CLA supplementation significantly decreased circulating leptin concentrations in the absence of any changes of fat mass.
Leptin may mediate the effect of CLA to decrease body fat.
Thus, 64 d of CLA supplementation in women produced a transient decrease in leptin levels but did not alter appetite.
Lipids  •  2000  |  View Paper
Supplementation with CLA before calving improved the recovery of plasma leptin levels in the early PP period (from the day of calving until wk 3 PP; treatment effect).
Journal of dairy science  •  2017  |  View Paper
In both genotypes, CLA significantly reduced serum triglycerides levels and down-regulated the mRNA expressions of CCAAT/enhancer binding protein α (C/EBPα) and leptin in white adipose tissue.
Food & function  •  2012  |  View Paper
10t 12c CLA treatment significantly decreased leptin and angiotensinogen expression in adipose tissue (4).
Acta poloniae pharmaceutica  •  2011  |  View Paper
In the presence of leptin, CLA depleted adiponectin but did not induce insulin resistance or macrophage infiltration.
Journal of Lipid Research  •  2008  |  View Paper
CLA inhibited both basal and insulin-stimulated leptin gene expression and secretion (-30 to -40%, P<0.05-0.01).
Furthermore, the inhibition of leptin and adiponectin production induced by CLA may contribute to insulin resistance observed in CLA-treated animals and humans.
These results indicate that CLA inhibits leptin and adiponectin secretion and suggest that increased anaerobic metabolism of glucose may be involved in these effects.
Molecular and Cellular Endocrinology  •  2007  |  View Paper
trans-10,cis-12 CLA (t10c12 CLA) reduced leptin secretion and fat accumulation.
Journal of medicinal food  •  2006  |  View Paper
On the other hand, serum adipocytokines, leptin and adiponectin, were drastically decreased by CLA feeding, and DHA supplementation did not affect those levels.
Journal of agricultural and food chemistry  •  2005  |  View Paper
Show More